vs
Side-by-side financial comparison of Cheniere Energy Partners, L.P. (CQP) and Henry Schein (HSIC). Click either name above to swap in a different company.
Cheniere Energy Partners, L.P. is the larger business by last-quarter revenue ($3.6B vs $3.4B, roughly 1.0× Henry Schein). Cheniere Energy Partners, L.P. runs the higher net margin — 5.2% vs 2.9%, a 2.2% gap on every dollar of revenue. On growth, Cheniere Energy Partners, L.P. posted the faster year-over-year revenue change (20.4% vs 7.7%). Over the past eight quarters, Cheniere Energy Partners, L.P.'s revenue compounded faster (37.9% CAGR vs 4.1%).
Total revenue of oil and gas companies is listed in billions of U.S. dollars. Total revenue is usually self-reported by companies, and often reported by neutral, unbiased, reliable publications. Reported data may be subsequently revised or restated due to a wide range of issues such as exchange rates, contract settlements, or mid-year discontinuation of products or services. Fiscal years are for January 1 to December 31, except where noted. Empty cells indicate that no data for that year has ...
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners. For 14 consecutive years, the company has been named as one of the World's Most Ethical Companies by Ethisphere, most recently in 2025.
CQP vs HSIC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.6B | $3.4B |
| Net Profit | $186.0M | $101.0M |
| Gross Margin | — | 30.9% |
| Operating Margin | 10.0% | 4.7% |
| Net Margin | 5.2% | 2.9% |
| Revenue YoY | 20.4% | 7.7% |
| Net Profit YoY | — | 7.4% |
| EPS (diluted) | — | $0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.6B | — | ||
| Q4 25 | $2.9B | $3.4B | ||
| Q3 25 | $2.4B | $3.3B | ||
| Q2 25 | $2.5B | $3.2B | ||
| Q1 25 | $3.0B | $3.2B | ||
| Q4 24 | $2.5B | $3.2B | ||
| Q3 24 | $2.1B | $3.2B | ||
| Q2 24 | $1.9B | $3.1B |
| Q1 26 | $186.0M | — | ||
| Q4 25 | $1.3B | $101.0M | ||
| Q3 25 | $506.0M | $101.0M | ||
| Q2 25 | $553.0M | $86.0M | ||
| Q1 25 | $641.0M | $110.0M | ||
| Q4 24 | $623.0M | $94.0M | ||
| Q3 24 | $635.0M | $99.0M | ||
| Q2 24 | $570.0M | $104.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.9% | ||
| Q3 25 | — | 30.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | — | 31.1% | ||
| Q3 24 | — | 31.3% | ||
| Q2 24 | — | 32.5% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 50.5% | 4.7% | ||
| Q3 25 | 29.0% | 4.9% | ||
| Q2 25 | 29.1% | 4.7% | ||
| Q1 25 | 27.6% | 5.5% | ||
| Q4 24 | 33.0% | 4.9% | ||
| Q3 24 | 40.2% | 4.9% | ||
| Q2 24 | 40.4% | 5.1% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 44.2% | 2.9% | ||
| Q3 25 | 21.0% | 3.0% | ||
| Q2 25 | 22.5% | 2.7% | ||
| Q1 25 | 21.4% | 3.5% | ||
| Q4 24 | 25.3% | 2.9% | ||
| Q3 24 | 30.9% | 3.1% | ||
| Q2 24 | 30.1% | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.85 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | — | $0.70 | ||
| Q1 25 | — | $0.88 | ||
| Q4 24 | — | $0.75 | ||
| Q3 24 | — | $0.78 | ||
| Q2 24 | — | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $279.0M | $156.0M |
| Total DebtLower is stronger | — | $2.3B |
| Stockholders' EquityBook value | — | $3.2B |
| Total Assets | $17.1B | $11.2B |
| Debt / EquityLower = less leverage | — | 0.71× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $279.0M | — | ||
| Q4 25 | $182.0M | $156.0M | ||
| Q3 25 | $121.0M | $136.0M | ||
| Q2 25 | $108.0M | $145.0M | ||
| Q1 25 | $94.0M | $127.0M | ||
| Q4 24 | $270.0M | $122.0M | ||
| Q3 24 | $331.0M | $126.0M | ||
| Q2 24 | $351.0M | $138.0M |
| Q1 26 | — | — | ||
| Q4 25 | $14.2B | $2.3B | ||
| Q3 25 | $14.2B | $2.2B | ||
| Q2 25 | $14.2B | $2.1B | ||
| Q1 25 | $14.7B | $2.0B | ||
| Q4 24 | $14.8B | $1.8B | ||
| Q3 24 | $14.8B | $1.9B | ||
| Q2 24 | $14.8B | $1.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.4B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | — | $3.5B |
| Q1 26 | $17.1B | — | ||
| Q4 25 | $17.4B | $11.2B | ||
| Q3 25 | $16.8B | $11.1B | ||
| Q2 25 | $16.9B | $10.9B | ||
| Q1 25 | $17.1B | $10.5B | ||
| Q4 24 | $17.5B | $10.2B | ||
| Q3 24 | $17.4B | $10.6B | ||
| Q2 24 | $17.5B | $10.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.71× | ||
| Q3 25 | — | 0.64× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $381.0M |
| Free Cash FlowOCF − Capex | — | $338.0M |
| FCF MarginFCF / Revenue | — | 9.8% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | — | 3.77× |
| TTM Free Cash FlowTrailing 4 quarters | — | $573.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $887.0M | $381.0M | ||
| Q3 25 | $658.0M | $174.0M | ||
| Q2 25 | $558.0M | $120.0M | ||
| Q1 25 | $665.0M | $37.0M | ||
| Q4 24 | $876.0M | $204.0M | ||
| Q3 24 | $691.0M | $151.0M | ||
| Q2 24 | $732.0M | $296.0M |
| Q1 26 | — | — | ||
| Q4 25 | $864.0M | $338.0M | ||
| Q3 25 | $610.0M | $141.0M | ||
| Q2 25 | $490.0M | $88.0M | ||
| Q1 25 | $605.0M | $6.0M | ||
| Q4 24 | $827.0M | $168.0M | ||
| Q3 24 | $652.0M | $117.0M | ||
| Q2 24 | $702.0M | $259.0M |
| Q1 26 | — | — | ||
| Q4 25 | 29.7% | 9.8% | ||
| Q3 25 | 25.4% | 4.2% | ||
| Q2 25 | 20.0% | 2.7% | ||
| Q1 25 | 20.2% | 0.2% | ||
| Q4 24 | 33.6% | 5.3% | ||
| Q3 24 | 31.7% | 3.7% | ||
| Q2 24 | 37.1% | 8.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 1.3% | ||
| Q3 25 | 2.0% | 1.0% | ||
| Q2 25 | 2.8% | 1.0% | ||
| Q1 25 | 2.0% | 1.0% | ||
| Q4 24 | 2.0% | 1.1% | ||
| Q3 24 | 1.9% | 1.1% | ||
| Q2 24 | 1.6% | 1.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.69× | 3.77× | ||
| Q3 25 | 1.30× | 1.72× | ||
| Q2 25 | 1.01× | 1.40× | ||
| Q1 25 | 1.04× | 0.34× | ||
| Q4 24 | 1.41× | 2.17× | ||
| Q3 24 | 1.09× | 1.53× | ||
| Q2 24 | 1.28× | 2.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CQP
| LNG revenues | $2.7B | 75% |
| LNG revenues-affiliate | $846.0M | 24% |
| Regasification revenues | $34.0M | 1% |
| Other revenues | $17.0M | 0% |
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
